Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Presse Medicale (Paris, France : 1983)|October 8, 2013
Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitidesPierre Charles, Boris Bienvenu, Bernard Bonnotte, et al.
Journal of Autoimmunity|October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)François Barde, Kevin Chevalier, Paul Decker, et al.
International Journal of Radiation Oncology, Biology, Physics|August 13, 2023
Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following RadiotherapyEric D Miller, Trudy Wu, Grant McKinley, et al.
Journal of Autoimmunity|August 3, 2023
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patientsJulien Rohmer, Yann Nguyen, Ludovic Trefond, et al.
International Journal of Cancer|August 19, 2024
Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapiesSujay Kalathoor, Sanam Ghazi, Beryl Otieno, et al.
Rheumatology (Oxford, England)|March 10, 2020
Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysisPierre Charles, Agnès Dechartres, Benjamin Terrier, et al.
Annals of the Rheumatic Diseases|April 27, 2018
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)Pierre Charles, Benjamin Terrier, Élodie Perrodeau, et al.
Clinical & Translational Immunology|September 17, 2021
Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritisMaxime Samson, Hélène Greigert, Marion Ciudad, et al.
Rheumatology (Oxford, England)|February 27, 2023
Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomesBoris Sorin, Michele Iudici, Mary-Jane Guerry, et al.
Annals of Internal Medicine|June 2, 2020
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized TrialPierre Charles, Élodie Perrodeau, Maxime Samson, et al.
Pageof 11